Viread and Dermatitis - atopic - a phase IV clinical study of FDA data

Summary:

Dermatitis - atopic is reported as a side effect among people who take Viread (tenofovir disoproxil fumarate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Hepsera, and have High blood pressure.

The phase IV clinical study analyzes which people have Dermatitis - atopic when taking Viread. It is created by eHealthMe based on reports of 51,434 people who have side effects when taking Viread from the FDA, and is updated regularly.

What is Viread?

Viread has active ingredients of tenofovir disoproxil fumarate. It is often used in hepatitis b. eHealthMe is studying from 51,542 Viread users. Check the latest studies of Viread.

What is Dermatitis - atopic?

Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 2,008 drugs and 1,972 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.

On Jul, 14, 2026

51,434 people reported to have side effects when taking Viread.
Among them, 14 people (0.03%) have Dermatitis - atopic.

Among these 14 people:

How long have people been on Viread when they have Dermatitis - atopic? *

What is the gender of people who have Dermatitis - atopic when taking Viread? *

female: 7.14 %
male: 92.86 %

What is the age of people who have Dermatitis - atopic when taking Viread? *

What are other drugs people take besides Viread? *

What are other side effects people have besides Dermatitis - atopic? *

High Blood Pressure: 7 people, 50.00%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 7 people, 50.00%
Stress And Anxiety: 7 people, 50.00%
Lacunar Infarction (a type of stroke): 7 people, 50.00%
Osteomalacia (softening of the bones due to a lack of vitamin d): 6 people, 42.86%
Disease Recurrence: 6 people, 42.86%
Back Pain: 6 people, 42.86%
Coccydynia (pain in the coccyx or tailbone area): 6 people, 42.86%
Splenomegaly (enlargement of spleen): 6 people, 42.86%
Neck Pain: 6 people, 42.86%

What are the existing conditions these people have? *

High Blood Pressure: 7 people, 50.00%
Insomnia (sleeplessness): 6 people, 42.86%
Urinary Tract Infection: 1 person, 7.14%
Pneumonia Klebsiella (pneumonia caused by bacteria klebsiella): 1 person, 7.14%
Mycobacterial Infection: 1 person, 7.14%
Hiv Test Positive: 1 person, 7.14%
Chronic Leukaemia (long lasting blood cell cancer): 1 person, 7.14%
Burkitt Lymphoma (cancer of the lymphatic system): 1 person, 7.14%
Atypical Mycobacterial Infection (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Viread and have Dermatitis - atopic?

- Check whether Dermatitis - atopic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Viread:

Viread (51,542 reports)

Browse all side effects of Viread:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis - atopic:

Dermatitis - atopic (2,008 drugs)

Browse all the conditions that are associated with Dermatitis - atopic:

Dermatitis - atopic (1,972 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tenofovir disoproxil fumarate (the active ingredients of Viread) and Viread (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.